Bliss GVS Pharma Ltd (BLISSGVS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 730684,
    "name": "Bliss GVS Pharma",
    "stock_name": "Bliss GVS Pharma",
    "full_name": "Bliss GVS Pharma Ltd",
    "name_url": "stocks-analysis/bliss-gvs-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "481.35",
    "chg": 6.8,
    "chgp": "1.43%",
    "dir": 1,
    "prev_price": "474.55",
    "mcapval": "5,039.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506197,
    "symbol": "BLISSGVS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE416D01022",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "9.59 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/bliss-gvs-pharma-730684-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 296.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs29695-4003082",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BlissGVSPharmaL_priceRelatedfactors_4003082.png",
        "date": "2026-05-21 12:35:33",
        "description": "Surging to a fresh 52-week and all-time high of Rs 296.95 on 21 May 2026, Bliss GVS Pharma Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a volatile backdrop."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-on-21-may-2026-4003074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BlissGVSPharmaL_priceRelatedfactors_4003074.png",
        "date": "2026-05-21 12:11:15",
        "description": ""
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 296.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs29685-3998570",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BlissGVSPharmaL_priceRelatedfactors_3998570.png",
        "date": "2026-05-19 09:39:27",
        "description": "Surging past its previous peaks, Bliss GVS Pharma Ltd touched a new 52-week high of Rs 296.85 on 19 May 2026, marking a remarkable 131.44% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price strength that has propelled the stock well ahead of the broader market’s subdued performance."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Ltd Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-all-time-high-at-rs-29685-on-19-may-2026-3998532",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BlissGVSPharmaL_priceRelatedfactors_3998532.png",
        "date": "2026-05-19 09:31:06",
        "description": ""
      },
      {
        "title": "Are Bliss GVS Pharma Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-bliss-gvs-pharma-ltd-latest-results-good-or-bad-3989946",
        "imagepath": "",
        "date": "2026-05-13 19:17:37",
        "description": "Bliss GVS Pharma Ltd's latest financial results for the quarter ended March 2026 reveal a complex picture of operational performance. The company reported record revenue of ₹256.99 crores, reflecting a year-on-year growth of 29.80%, which is a notable improvement compared to the previous year's performance. Additionally, net profit surged to ₹35.58 crores, marking a significant year-on-year increase of 128.96%. This performance was further complemented by an operating margin of 17.29%, which also showed substantial year-on-year growth.\n\nDespite these positive quarterly results, there are underlying concerns regarding the company's long-term growth trajectory. The five-year sales compound annual growth rate (CAGR) stands at just 8.97%, while the operating profit (EBIT) has grown at a mere 3.85% annually over the same period. These figures suggest potential structural challenges that could impact future perfo..."
      },
      {
        "title": "Bliss GVS Pharma Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-reports-strong-quarterly-upswing-amid-positive-financial-trend-3989468",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BlissGVSPharmaL_fintrenddot_3989468.png",
        "date": "2026-05-13 11:00:08",
        "description": "Bliss GVS Pharma Ltd has demonstrated a marked turnaround in its financial performance for the quarter ended March 2026, upgrading its financial trend from flat to positive. The pharmaceutical micro-cap has posted record quarterly figures across key metrics, signalling renewed operational strength and investor confidence amid a challenging sector backdrop."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Ltd Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-on-13-may-2026-3989356",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BlissGVSPharmaL_priceRelatedfactors_3989356.png",
        "date": "2026-05-13 10:21:07",
        "description": ""
      },
      {
        "title": "Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 283.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-hits-new-52-week-high-at-rs28355-3987074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BlissGVSPharmaL_priceRelatedfactors_3987074.png",
        "date": "2026-05-12 09:44:40",
        "description": "From a 52-week low of Rs 114.45 to a fresh peak of Rs 283.55 on 12 May 2026, Bliss GVS Pharma Ltd has surged an impressive 135.03% over the past year, significantly outperforming the Sensex which declined by 8.57% in the same period. This milestone reflects a powerful momentum shift driven predominantly by technical factors rather than broad market tailwinds."
      },
      {
        "title": "Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Ltd Reaches All-Time High",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bliss-gvs-pharma-ltd-stock-hits-all-time-high-at-rs28355-3987044",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BlissGVSPharmaL_priceRelatedfactors_3987044.png",
        "date": "2026-05-12 09:31:02",
        "description": ""
      }
    ],
    "total": 15,
    "sid": "730684",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/bliss-gvs-pharma-730684"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "11-Jun-2026",
      "details": "We would like to inform you that the ESOP Allotment Committee at its meeting held today i.e. June 11 2026 has approved the allotment of 267250 equity shares of face value Re.1/- each to the eligible employees who have exercised their options under Bliss GVS Pharma Limited-Employee Stock Option Plan (Bliss GVS-ESOP 2019)",
      "source": "BSE"
    },
    {
      "caption": "Draft Letter of Offer",
      "datetime": "09-Jun-2026",
      "details": "SBI Capital Markets Ltd (Manager to the Open Offer) has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Bliss GVS Pharma Ltd (Target Company).",
      "source": "BSE"
    },
    {
      "caption": "Submission Of Draft Letter Of Offer In Relation To The Open Offer Made To The Public Shareholders Of Bliss GVS Pharma Limited Under The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011",
      "datetime": "09-Jun-2026",
      "details": "Please find attached a copy of the Draft Letter of Offer (DLOF) from SBI Capital Markets Limited the Manager to the Open Offer.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has declared <strong>50%</strong> dividend, ex-date: 18 Feb 26",
          "dt": "2026-02-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08",
          "dt": "2008-03-11",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Bliss GVS Pharma Ltd has announced <strong>3:5</strong> bonus issue, ex-date: 26 Sep 08",
          "dt": "2008-09-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 296.95

2026-05-21 12:35:33

Surging to a fresh 52-week and all-time high of Rs 296.95 on 21 May 2026, Bliss GVS Pharma Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a volatile backdrop.

Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Reaches All-Time High

2026-05-21 12:11:15

Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 296.85

2026-05-19 09:39:27

Surging past its previous peaks, Bliss GVS Pharma Ltd touched a new 52-week high of Rs 296.85 on 19 May 2026, marking a remarkable 131.44% gain over the past year. This milestone comes amid a backdrop of strong technical momentum and sustained price strength that has propelled the stock well ahead of the broader market’s subdued performance.

Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Ltd Reaches All-Time High

2026-05-19 09:31:06

Are Bliss GVS Pharma Ltd latest results good or bad?

2026-05-13 19:17:37

Bliss GVS Pharma Ltd's latest financial results for the quarter ended March 2026 reveal a complex picture of operational performance. The company reported record revenue of ₹256.99 crores, reflecting a year-on-year growth of 29.80%, which is a notable improvement compared to the previous year's performance. Additionally, net profit surged to ₹35.58 crores, marking a significant year-on-year increase of 128.96%. This performance was further complemented by an operating margin of 17.29%, which also showed substantial year-on-year growth. Despite these positive quarterly results, there are underlying concerns regarding the company's long-term growth trajectory. The five-year sales compound annual growth rate (CAGR) stands at just 8.97%, while the operating profit (EBIT) has grown at a mere 3.85% annually over the same period. These figures suggest potential structural challenges that could impact future perfo...

Bliss GVS Pharma Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend

2026-05-13 11:00:08

Bliss GVS Pharma Ltd has demonstrated a marked turnaround in its financial performance for the quarter ended March 2026, upgrading its financial trend from flat to positive. The pharmaceutical micro-cap has posted record quarterly figures across key metrics, signalling renewed operational strength and investor confidence amid a challenging sector backdrop.

Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Ltd Reaches All-Time High

2026-05-13 10:21:07

Broad-Based Technical Strength Lifts Bliss GVS Pharma Ltd to 52-Week High of Rs 283.55

2026-05-12 09:44:40

From a 52-week low of Rs 114.45 to a fresh peak of Rs 283.55 on 12 May 2026, Bliss GVS Pharma Ltd has surged an impressive 135.03% over the past year, significantly outperforming the Sensex which declined by 8.57% in the same period. This milestone reflects a powerful momentum shift driven predominantly by technical factors rather than broad market tailwinds.

Strong Momentum Meets Stretched Valuations as Bliss GVS Pharma Ltd Reaches All-Time High

2026-05-12 09:31:02

View All News